• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    2 Contact Hour(s)

    Release Date

    Monday, April 13, 2020

    Offline Date

    Tuesday, April 13, 2021

    ACPE Expiration Date

    Saturday, March 4, 2023

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      Multiple Sclerosis is a complex neurologic disease that affects the brain and spinal cord (central nervous system). Symptoms vary, because the location and severity of each attack can be different.  Because pharmacotherapy plays a prominent role in treating multiple sclerosis, it is also a perfect opportunity for the pharmacist to be involved in getting treatment right.  This program for pharmacists will enhance their understanding of multiple sclerosis, pharmacotherapy, counseling points, and information needed to work with the patient to maximize the benefits of medications and limit side effects.

      Handouts

      • Slide Document :   19221H01_2pp.pdf
      • Slide Document :   19221H01_6pp.pdf

      Financial Support By

      Biogen
    • Pharmacist

      Identify the factors affecting adherence in individuals with MS and strategies to optimize long-term patient adherence
      Review the pharmacist’s role in optimizing patient outcomes in the management of MS.
      Briefly outline the etiology, pathophysiology, and impact of multiple sclerosis.
      Describe the latest evidence-based therapeutic regimens for relapsing MS across care settings.
      Outline emerging therapies for MS and where they belong in the overall treatment plan.

      Nurse

      Briefly outline the etiology, pathophysiology, and impact of multiple sclerosis.
      Outline emerging therapies for MS and where they belong in the overall treatment plan.
      Identify the factors affecting adherence in individuals with MS and strategies to optimize long-term patient adherence
      Describe the latest evidence-based therapeutic regimens for relapsing MS across care settings.
      Review the pharmacist’s role in optimizing patient outcomes in the management of MS.
    • Activity Type

      Knowledge

      CE Broker

      20-774114

      Universal Activity Number

      Pharmacist 0798-0000-19-221-H01-P
      Nurse 0798-0000-19-221-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Jon  Wietholter, PharmD, BCPS
      Neurology Faculty Expert, American Society of Health-Systems Pharmacists (ASHP); Clinical Associate Professor, West Virginia University School of Pharmacy, Morgantown, WV; Adjunct Associate Professor, West Virginia University School of Medicine

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).